Wednesday, November 17, 2021 11:08:18 AM
https://www.envivabiomass.com/wp-content/uploads/Tyrone%20Williams_CC_final.mp4
Recent EVA News
- Enviva Receives NYSE Notice Regarding Delayed Form 10-K Filing • PR Newswire (US) • 04/08/2024 08:30:00 PM
- Enviva Announces Court Approval of DIP and the Commencement of the DIP Syndication Process • Business Wire • 03/15/2024 06:36:00 PM
- Enviva Announces Comprehensive Agreements to Delever Balance Sheet and Strengthen Financial Position • Business Wire • 03/13/2024 02:33:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:03:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:02:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:01:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:30:04 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:15:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 02:03:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:54:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:46:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:39:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:59:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:57:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:57:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/29/2024 11:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:30:18 PM
- Enviva Receives Continued Listing Standard Notice from the NYSE • Business Wire • 01/29/2024 09:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 11:15:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 12:53:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/23/2024 12:40:32 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/19/2024 11:22:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 01:30:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/29/2023 10:14:38 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/29/2023 09:57:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM